Abstract
The oestrogen receptor status of the soluble fraction of a tumour biopsy is now accepted as a valuable tool in the management of advanced breast cancer [11]. Soluble receptor status of primary disease may also be of value as a prognostic index [3, 20], although this value might be limited to patients with intermediate nodal involvement [19]. However, the presence of soluble receptors alone is not an absolute index of hormonal dependence [22]. Hormone-receptor complex might fail to undergo translocation/activation [37] or to bind to the correct acceptor sites on the DNA [33]. Loss of hormonal dependence through a breakdown at the post-transcriptional level is also a possibility. For these reasons several parameters of oestrogen response have been studied in breast tumour biopsies. Measurement of the presence of progesterone receptor (a product of oestrogen action) has proved productive [11]. The suggestion that a useful index of hormonal dependence might simply be the presence of nuclear-bound oestrogen receptor [21] has been followed up by several groups [2, 15, 29, 38].
Work from our own laboratory was supported, in part, by the Cancer Research Campaign, to whom we are very grateful. C. L. is pleased to acknowledge receipt of a Medical Research Council studentship. We are much indebted to our various surgical colleagues and, in particular, to David Smith and Ken Calman
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson JN, Clark JH, Peck EJ Jr (1972) Oestrogen and nuclear binding sites: determination of specific sites by [3H] oestradiol exchange. Biochem J 126: 561–567
Barnes DM, Skinner LG, Ribeiro GG (1979) Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer? Br J Cancer 40: 862–865
Bishop HM, Blarney RW, Elston CW, Haybittle JL, Nicholson RI, Griffiths K (1979) Relationship of oestrogen-receptor status to survival in breast cancer. Lancet 2: 283–284
Blankenstein MA, Peters-Mechielsen MJ, Mulder E, Van Der Molen HJ (1980) Estimation of total oestrogen receptors in DMB A-induced rat mammary tumors by exchange of nuclear bound ligand at low temperature; a comparison with rat uterus. J Steroid Biochem 13: 557–564
British Breast Group (1974) Assessment of response to treatment in advanced breast cancer. Lancet 2: 38–39
Castagnetta L, Lo Casto M, Mercadante T, Polito L, Cowan S, Leake RE (1983) Intratumoural variation of oestrogen receptor status in endometrial cancer. Br J Cancer 47: 261–267
Chamness GC, McGuire WL (1980) Methods for analyzing steroid receptors in human breast cancer. In: McGuire WL (ed) Breast cancer, vol 3. Plenum Medical, New York, p 149
Clark JH, Peck EJ Jr (1976) Nuclear retention of receptor-oestrogen complex and nuclear acceptor sites. Nature 260: 635–637
Delarue JC, Bohoun C (1980) Utilization of the measurement of hormone receptors in the treatment of breast cancer in women. Ann Biol Clin (Paris) 38: 293–296
Duffy MJ, O’Connell M (1981) Estrogens, estradiol receptors and peroxidase activity in human mammary carcinomas. Eur J Cancer 17: 711–716
Edwards DP, Chamness GC, McGuire WL (1979) Estrogen and progesterone receptor proteins in breast cancer. Biochim Biophys Acta 560: 457–486
Edwards DP, Martin PM, Horwitz KB, Chamness GC, McGuire WL (1980) Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exp Cell Res 127: 197–213
Fazekas AG, MacFarlane JK (1980) Studies on cytosol and nuclear binding of estradiol in human breast cancer. J Steroid Biochem 13: 613–622
Garola RE, McGuire WL (1977) An improved assay for nuclear oestrogen receptor in experimental and human breast cancer. Cancer Res 37: 3333–3337
Hahnel R, Partridge RK, Gavet L, Twaddle E, Ratajczak T (1980) Nuclear and cytoplasmic estrogen receptors and progesterone receptors in breast cancer. Eur J Cancer 16: 1027–1033
Hawkins RA, Roberts MM, Forrest APM (1980) Oestrogen receptors and breast cancer: current status. Br J Surg 67: 152–169
Hayward JL, Carbonne PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13: 89–94
Horwitz KB, McGuire WL (1980) Nuclear estrogen receptors: effect of inhibitors on processing and steady state levels. J Biol Chem 255: 9699–9705
Howat JMT, Barnes DM (1981) Oestrogen receptor status and management of breast cancer. Lancet 1: 1317
Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671
Laing L, Smith MG, Caiman KC, Smith DC, Leake RE (1977) Nuclear oestrogen receptors and treatment of breast cancer. Lancet 2: 168–169
Leake RE (1976) Current views on oestrogen receptors. Trends Biochem Sci 1: 137–139
Leake RE, Laing L, Smith DC (1979) A role for nuclear oestrogen receptors in prediction of therapy regime for breast cancer patients. In: King RJB (ed) Steroid receptor assays in human breast tumours. Alpha Omega, Cardiff, p 73
Leake RE (1980) Methodology of steroid hormone receptor determination in breast cancer. In: Taylor RW (ed) Progestogens in the management of hormonal responsive carcinomas. Medicine Publishing Foundation, Oxford, p 3
Leake RE, Laing L, Caiman KC, Macbeth FR, Crawford D, Smith DC (1981) Oestrogen-re¬ceptor status and endocrine therapy of breast cancer: response rates and status stability. Br J Cancer 43: 59–66
Leake RE, Laing L, McArdle C, Smith DC (1981) Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. Br J Cancer 43: 67–71
MacFarlane JK, Fleiszer D, Fazekas AG (1980) Studies on estrogen receptors and regression in human breast cancer. Cancer 45: 2998–3003
Osborne CK, Yochmowitz MG, Knight WA, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884–2888
Panko WB, MacLeod RM (1978) Uncharged nuclear receptors for estrogen in breast cancers. Cancer Res 38: 1948–1951
Paridaens R, Sylvester RJ, Ferrazzi E, Legros N, Leclercq G, Heuson JC (1980) Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46: 2889–2895
Ruh TS, Baudendistel LJ (1977) Different nuclear binding sites for antiestrogen and estrogen receptor complexes. Endocrinology 100: 420–426
Samaan NA, Buzdar AU, Aldinger KA, Schultz PN, Yang KP, Romsdahl MM, Martin R (1981) Estrogen receptor: a prognostic factor in breast cancer. Cancer 47: 554–560
Sato B, Nomura Y, Nakao K, Ochi H, Matsumoto K (1981) DNA binding ability of estrogen receptor from human breast cancer. J Steroid Biochem 14: 295–303
Schoenberg DR, Clark JK (1980) A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor. Endocrinology 106: 56–60
Silfversward C, Skoog L, Humla S, Gustafsson SA, Nordenskjold B (1980) Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma. Eur J Cancer 16: 59–63
Taylor RN, Swaneck GE, Smith RG (1980) Correlation of nuclear acceptor sites for oestrogen receptors with gene transcription in vitro. Biochem J 192: 385–393
Thorsen T, Stoa KF (1979) Nuclear uptake of oestradiol-17/3 in human mammary tumour tissue. J Steroid Biochem 10: 595–599
Thorsen T (1980) Occupied and unoccupied oestradiol receptor in human breast tumour cytosol. J Steroid Biochem 13: 405–408
Tilley WD, Keightley DD, Cant ELM (1978) Inter-site variation of oestrogen receptors in human breast cancers. Br J Cancer 38: 544–546
Tisdale MJ (1977) Inhibition of prostaglandin synthetase by anti-tumour agents. Chem Biol Interact 18: 91–102
Zava DT, Harrington NY, McGuire WL (1976) Nuclear estradiol receptor in the adult rat uterus: a new exchange assay. Biochemistry 15: 4292–4297
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Cowan, S., Love, C., Leake, R.E. (1984). The Value of Determination of Nuclear Oestrogen Receptors in Breast Cancer Biopsies. In: Leclercq, G., Toma, S., Paridaens, R., Heuson, J.C. (eds) Clinical Interest of Steroid Hormone Receptors in Breast Cancer. Recent Results in Cancer Research, vol 91. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82188-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-82188-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82190-5
Online ISBN: 978-3-642-82188-2
eBook Packages: Springer Book Archive